secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001437749-26-006991
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva Pharma announces 1:20 reverse stock split to regain Nasdaq minimum bid price compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1:20 ratio effective 12:01 a.m. ET on March 9, 2026; no fractional shares, rounding up.
- Nasdaq Staff granted an exception to demonstrate compliance with $1 bid price requirement through March 27, 2026.
- Company received delisting notice in Nov 2025; hearing held Jan 8, 2026; exception granted.
- If compliance not regained, stock may be delisted, harming liquidity and capital access.
- CUSIP changes to 76152G 209; trading symbol remains RVPH.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774926006991/0001437749-26-006991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774926006991/rvph20260227_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-006991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer